<DOC>
	<DOCNO>NCT02948946</DOCNO>
	<brief_summary>The purpose study evaluate well investigational blood test performs . The study look sensitivity specificity blood-based multitranscriptome assay ( NETest ) .</brief_summary>
	<brief_title>Clinical Utility Assay Biomarker Gastroenteropancreatic Lung Neuroendocrine Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>NET Cohort Patients histologically cytologically proven diagnosis grade , stage NET GEP lung origin ; In first stage study ( initial 50 patient ) patient stage IV , welldifferentiated tumor ( G1/G2 ) enrol . Patients stable progressive disease , document scan ( CT , MRI ) ; Progression status document case report form ( CRF ) . Allowed prior therapy include : . ) Surgery ( tumor surgery least four week prior study entry ) ; b . ) Locoregional therapy : chemoembolization , radioembolization , radiofrequency ablation , radiotherapy least six week prior study entry ; c. ) Any number previous line systemic therapy , provide cytotoxic therapy ( chemotherapy , PRRT ) discontinue least 4 week prior study entry . NonNET Cohort Healthy participant Patients histologically cytologically proven diagnosis grade , stage GI malignancy . NET Cohort Patients treatment cytotoxic agent ( chemotherapy , PRRT ) . Patients renal insufficiency congestive heart failure . No active malignancy within 3 year enrolment except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , adequately treated stage I II cancer patient currently complete remission . NonNET Cohort Patients GI malignancy neuroendocrine differentiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>pancreatic cancer</keyword>
</DOC>